pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›Priftin
drug
save

rifapentine

Marketedupdated 3mo ago
by Sanofi-Aventis US LLC
Approved
community read0 votes

🐶 often sniffed alongside

top 5
  • drugPRIFTIN68 co-mentions · 17 sources
  • tagApproval68 co-mentions · 17 sources
  • company$SNYSanofi34 co-mentions · 17 sources
  • company$SNYNFSanofi34 co-mentions · 17 sources
  • tagSmall Molecule34 co-mentions · 17 sources

all catalysts(17)

approval · 17
Jun 22, 1998
approval
28y ago
PRIFTIN (RIFAPENTINE) — FDA approval
rifapentine
→
Apr 21, 1999
approval
27y ago
PRIFTIN (RIFAPENTINE) — FDA approval
rifapentine
→
Jul 22, 1999
approval
27y ago
PRIFTIN (RIFAPENTINE) — FDA approval
rifapentine
→
Dec 10, 1999
approval
27y ago
PRIFTIN (RIFAPENTINE) — FDA approval
rifapentine
→
Sep 13, 2000
approval
26y ago
PRIFTIN (RIFAPENTINE) — FDA approval
rifapentine
→
Oct 20, 2000
approval
26y ago
PRIFTIN (RIFAPENTINE) — FDA approval
rifapentine
→
Dec 12, 2000
approval
26y ago
PRIFTIN (RIFAPENTINE) — FDA approval
rifapentine
→
Jun 1, 2009
approval
17y ago
PRIFTIN (RIFAPENTINE) — FDA approval
rifapentine
→
Jul 30, 2010
approval
16y ago
PRIFTIN (RIFAPENTINE) — FDA approval
rifapentine
→
Nov 20, 2014
approval
12y ago
PRIFTIN (RIFAPENTINE) — FDA approval
rifapentine
→
Nov 25, 2014
approval
12y ago
PRIFTIN (RIFAPENTINE) — FDA approval
rifapentine
→
Jul 1, 2015
approval
11y ago
PRIFTIN (RIFAPENTINE) — FDA approval
rifapentine
→
Aug 7, 2015
approval
11y ago
PRIFTIN (RIFAPENTINE) — FDA approval
rifapentine
→
Jun 5, 2020
approval
6y ago
PRIFTIN (RIFAPENTINE) — FDA approval
rifapentine
→
Jun 5, 2020
approval
6y ago
PRIFTIN (RIFAPENTINE) — FDA approval
rifapentine
→
Jun 9, 2020
approval
6y ago
PRIFTIN (RIFAPENTINE) — FDA approval
rifapentine
→
Jan 27, 2026
approval
7mo ago
PRIFTIN (RIFAPENTINE) — FDA approval
rifapentine
→
view all 17 catalysts →

Trials studying rifapentine

  • phase2TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatmentcompletedn=334
  • phase2Tuberculosis Clinical Trials Consortium Study 35completedn=69
  • phase4Ultra Curto (Ultra Short) TB Prevention Therapycompletedn=531
  • phase2Drug-Drug Interactions Between Rifapentine and Dolutegravir in HIV/LTBI Co-Infected Individualsterminatedn=37

News(0)

no news has mentioned this drug yet

brand
Priftin
generic
rifapentine
indication
Pulmonary Tuberculosis
phase
marketed
Data sources
openFDA · ClinicalTrials.gov
last refreshed just now
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?